Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Daemen J, et al. Among authors: kukreja n. Lancet. 2007 Feb 24;369(9562):667-78. doi: 10.1016/S0140-6736(07)60314-6. Lancet. 2007. PMID: 17321312
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Daemen J, et al. Among authors: kukreja n. Am J Cardiol. 2007 Apr 15;99(8):1027-32. doi: 10.1016/j.amjcard.2006.11.070. Epub 2007 Mar 6. Am J Cardiol. 2007. PMID: 17437722 Clinical Trial.
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Among authors: kukreja n. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry.
García-García HM, Daemen J, Kukreja N, Tanimoto S, van Mieghem CA, van der Ent M, van Domburg RT, Serruys PW. García-García HM, et al. Among authors: kukreja n. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):635-9. doi: 10.1002/ccd.21249. Catheter Cardiovasc Interv. 2007. PMID: 17960629
Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions.
Tsuchida K, Daemen J, Tanimoto S, García-García HM, Kukreja N, Vaina S, Ong AT, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Tsuchida K, et al. Among authors: kukreja n. Int J Cardiol. 2008 Oct 13;129(3):348-53. doi: 10.1016/j.ijcard.2007.08.018. Epub 2007 Nov 26. Int J Cardiol. 2008. PMID: 18031845
The future of drug-eluting stents.
Kukreja N, Onuma Y, Daemen J, Serruys PW. Kukreja N, et al. Pharmacol Res. 2008 Mar;57(3):171-80. doi: 10.1016/j.phrs.2008.01.012. Epub 2008 Feb 2. Pharmacol Res. 2008. PMID: 18339557 Review.
124 results